We look forward to more peptide drugs making the journey from laboratory to clinic, clinic to market, and market to patients sooner rather than later, making contributions to human health and well-being
More serious risks are uncommon, but its essential to work with a healthcare provider, especially if pregnancy or cancer is a concern
Zhou S, Zhang X, Ni W, He Y, Li M, Wang C, et al
KawasakiKKondohEChigusaYKawamuraYMogamiHTakedaSet al
Clinical studies have not generally documented serious side effects that require discontinuation of liraglutide, but gastrointestinal side effects, such as nausea, vomiting, and digestive disorders, often occur